US Department of Health and Human Services has signed an agreement with Astra Zeneca Plc for development and supply of the company â€™s Covid 19 antibody treatment , a cocktail of two monoclonal antibodies , a similar class of drugs that was administered to President Donald Trump . 
The agency will provide nearly $ 486 million to Astra Zeneca for two Phase 3 clinical trials as well as a large scale manufacturing demonstration project and supply of AZD7442 doses in the US . 
